Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Screening of novel DPP-IV inhibitory peptides derived from bovine milk proteins using a peptide array platform

J Biosci Bioeng. 2023-12; 
Sayuri Arai, Masaki Kurimoto, Hajime Nakada, Masayoshi Tanaka, Hiroshi Ochi, Miyuki Tanaka, Mina Okochi
Products/Services Used Details Operation
Catalog Peptides … Synthetic peptides (net peptide, >95% purity) were purchased from GenScript (Piscataway, NJ, USA). Peptide solutions were prepared by dissolving the peptides in water to 1000 μM. … Get A Quote

摘要

Dipeptidyl peptidase IV (DPP-IV) has become an important target in the prevention and treatment of diabetes. Although many DPP-IV inhibitory peptides have been identified by a general approach involving the repeated fractionation of food protein hydrolysates, the obtained results have been dependent on the content of each peptide and fractionation conditions. In the present study, a peptide array that provides comprehensive assays of peptide sequences was used to identify novel DPP-IV inhibitory peptides derived from bovine milk proteins; these peptides were then compared with those identified using the general approach. While the general approach identified only known peptides that were abundant in the hydroly... More

关键词

DPP-IV inhibitory peptide, Fractionation, Milk protein hydrolysate, Peptide array, Screening approach
XML 地图